Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity

COVID-19 is a concerning global pandemic. Common manifestations are fever and respiratory symptoms. In addition, recent studies reported dermatological manifestations as extrapulmonary signs. One of these is telogen effluvium which is related to post COVID-19 comorbidities. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyfi, Shahram, Alijanpour, Robabeh, Aryanian, Zeinab, Ezoji, Khadijeh, Mahmoudi, Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262270/
https://www.ncbi.nlm.nih.gov/pubmed/35815081
http://dx.doi.org/10.25122/jml-2021-0380
_version_ 1784742457219481600
author Seyfi, Shahram
Alijanpour, Robabeh
Aryanian, Zeinab
Ezoji, Khadijeh
Mahmoudi, Mahdi
author_facet Seyfi, Shahram
Alijanpour, Robabeh
Aryanian, Zeinab
Ezoji, Khadijeh
Mahmoudi, Mahdi
author_sort Seyfi, Shahram
collection PubMed
description COVID-19 is a concerning global pandemic. Common manifestations are fever and respiratory symptoms. In addition, recent studies reported dermatological manifestations as extrapulmonary signs. One of these is telogen effluvium which is related to post COVID-19 comorbidities. The aim of this study was to assess the prevalence of telogen effluvium among COVID-19 patients. This observational cross-sectional study included 198 patients who were admitted for COVID-19. The PCR test was performed to detect positive cases. After discharge, all patients were interviewed about hair loss. Of these patients, 79 were male (39.9%), and 119 were female (60.1%). The age ranged from 18 to 85 years old. 48 patients showed hair loss. Telogen effluvium (TE) is one of the consequences of the COVID-19 pandemic. COVID-19 leads to more medications and stress situations, which trigger TE.
format Online
Article
Text
id pubmed-9262270
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-92622702022-07-08 Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity Seyfi, Shahram Alijanpour, Robabeh Aryanian, Zeinab Ezoji, Khadijeh Mahmoudi, Mahdi J Med Life Original Article COVID-19 is a concerning global pandemic. Common manifestations are fever and respiratory symptoms. In addition, recent studies reported dermatological manifestations as extrapulmonary signs. One of these is telogen effluvium which is related to post COVID-19 comorbidities. The aim of this study was to assess the prevalence of telogen effluvium among COVID-19 patients. This observational cross-sectional study included 198 patients who were admitted for COVID-19. The PCR test was performed to detect positive cases. After discharge, all patients were interviewed about hair loss. Of these patients, 79 were male (39.9%), and 119 were female (60.1%). The age ranged from 18 to 85 years old. 48 patients showed hair loss. Telogen effluvium (TE) is one of the consequences of the COVID-19 pandemic. COVID-19 leads to more medications and stress situations, which trigger TE. Carol Davila University Press 2022-05 /pmc/articles/PMC9262270/ /pubmed/35815081 http://dx.doi.org/10.25122/jml-2021-0380 Text en © 2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Original Article
Seyfi, Shahram
Alijanpour, Robabeh
Aryanian, Zeinab
Ezoji, Khadijeh
Mahmoudi, Mahdi
Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
title Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
title_full Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
title_fullStr Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
title_full_unstemmed Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
title_short Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
title_sort prevalence of telogen effluvium hair loss in covid-19 patients and its relationship with disease severity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262270/
https://www.ncbi.nlm.nih.gov/pubmed/35815081
http://dx.doi.org/10.25122/jml-2021-0380
work_keys_str_mv AT seyfishahram prevalenceoftelogeneffluviumhairlossincovid19patientsanditsrelationshipwithdiseaseseverity
AT alijanpourrobabeh prevalenceoftelogeneffluviumhairlossincovid19patientsanditsrelationshipwithdiseaseseverity
AT aryanianzeinab prevalenceoftelogeneffluviumhairlossincovid19patientsanditsrelationshipwithdiseaseseverity
AT ezojikhadijeh prevalenceoftelogeneffluviumhairlossincovid19patientsanditsrelationshipwithdiseaseseverity
AT mahmoudimahdi prevalenceoftelogeneffluviumhairlossincovid19patientsanditsrelationshipwithdiseaseseverity

Ejemplares similares